Natus Medical Incorporated / Fundamentals
Income statement
- Net revenue
€407.97M - Cost of goods sold
€175.45M - Gross profit
€232.52M - SG&A expenses
€142.70M - R&D expenses
€47.33M - EBITDA
€41.58M - D&A
€23.46M - EBIT
€18.81M - Interest expenses
€1.17M - EBT
€16.94M - Tax expenses
€6.12M - Net income
€10.82M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€5.72M - Changes in working capital
-€10.56M - Operating cash flow
€41.10M - Capex
€3.37M - Other investing cash flow
€1.43M - Net investing cash flow
-€2.43M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€31.45M - Net financing cash flow
-€31.45M - Foreign exchange effects
-€4.04M - Net change in cash
€3.19M - Cash at end of period
€71.89M - Free cash flow
€44.47M
Balance sheet
- Cash and cash equivalents
€71.89M - Cash and short-term investments
€71.89M - Total receivables
€88.46M - Inventory
€61.62M - Other current assets
€22.63M - Total current assets
€244.60M - Property, plant & equipment
€25.09M - Goodwill
€126.50M - Intangible assets
€51.02M - Long-term investments
€0.00 - Other non-current assets
€17.26M - Total non-current assets
€239.95M - Total assets
€484.55M - Accounts payable
€29.29M - Short-term debt
€3.82M - Other current liabilities
€40.25M - Total current liabilities
€96.26M - Long-term debt
€4.91M - Deferred tax liabilities
€1.24M - Other non-current liabilities
€14.61M - Total non-current liabilities
€20.76M - Total liabilities
€117.02M - Common stock
€306.48M - Retained earnings
€73.69M - Other equity
-€12.64M - Total equity
€367.53M - Total liabilities and shareholders' equity
€484.55M
Company information
- Market capitalization
€0.00 - Employees
1.4K - Enterprise Value
-€64.06M
Company ratios
- Gross margin
-
57.0% Much better than peer group: -100.9% - EBITDA margin
-
10.2% Much better than peer group: -815.2% - EBIT margin
-
4.6% Much better than peer group: -875.2% - EBT margin
-
4.2% Much better than peer group: -1,011.8% - Net margin
-
2.7% Much better than peer group: -846.5% - ROE
-
2.9% Better than peer group: -3.3% - ROA
-
2.2% Much better than peer group: -18.1% - Asset turnover
-
84.2% Much better than peer group: 57.2% - FCF margin
-
9.2% Much better than peer group: -703.6% - FCF yield
0.0% - Efficiency ratio
89.8% - Net sales per employee
-
€291.41K - Net income per employee
-
€7.73K